Now playing Next Business Novo Nordisk owner invests millions in quantum computing Novo Holdings, the parent company of the maker of weight-loss drugs Ozempic and Wegovy, is investing millions to create a global innovation hub for quantum technology in Denmark. 02/05/2024
Now playing Next Business Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth Danish pharmaceutical titan Novo Nordisk, the maker of Ozempic and Wegovy, announces a significant year-over-year increase in net profit and sales for the first quarter of 2024. 02/05/2024
Now playing Next Economy How reliant are European nations on North Sea infrastructure? Countries like the UK and Norway are still significantly reliant on North Sea energy resources. However, harsher tax measures have led to several energy companies, such as Shell, pulling back from their offshore oil fields. 10/04/2024
Now playing Next Culture news Miss France Museum set to open on the French Riviera in 2025 Forget Cannes’ famed Croisette and the lavender fields of Grasse – the Côte d'Azur will soon be home to another unique attraction: the first ever Miss France Museum. 09/04/2024
Now playing Next Health news Why are Nordic countries so happy and what can we learn from them? Happiness and general well-being are not about money, but they do have something to do with a wallet. 23/03/2024
Now playing Next Green News Is Italy’s transport minister on a ‘crusade’ against cycling? Climate campaigners and bereaved families are urging the government to scrap a ‘backwards’ road code reform. 23/03/2024
Now playing Next Europe News Nordics buck trend in EU elections poll Sweden, Denmark and Finland may be among the happiest nations on earth, but their voters don’t seem too content with Green or Liberal politicians. 21/03/2024
Now playing Next Experiences A change of scene on the Seine: Where to take a workation in Paris These quirky coworking spaces give a taste of life in the French capital. 17/03/2024
Now playing Next Business How much higher can Novo Nordisk shares go? Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy, has led to a surge in market value and positive analyst outlook. 14/03/2024
Now playing Next Business Nord Stream sues London insurers over pipeline blasts Insurance firms in England are being sued by Nord Stream after refusing to cover pipeline sabotage costs. 13/03/2024
Now playing Next Tech News Prepare for more GPS blocking in NATO countries, expert says There could be more GPS disruption in Nordic countries now that NATO operates there, a defence expert said. 13/03/2024
Now playing Next Business Novo Nordisk expands lead on Tesla on upbeat obesity drug trial Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy. 08/03/2024
Now playing Next Travel News Inside Eurostar’s struggle with Brexit, strikes and competitors One passenger vowed to never travel with Eurostar again after last-minute strikes ruined his Christmas plans. 03/03/2024
Now playing Next euronews WITNESS Inside Marseille’s deadly drug wars: Why are youths killing youths? Forty-nine people were killed in drug-related shoot-outs between rival gangs in Marseille in 2023 - and the killing is ongoing. Is the situation in the French port city spiralling out of control? Euronews Witness heads south to find out. 01/03/2024
Now playing Next France Probe into theft of bag thought to have contained Olympics plans Paris city hall confirmed that a stolen USB memory stick did not contain police security plans for the 2024 Olympic Games. 28/02/2024
Now playing Next Destinations Set jetting: The One Day filming spots you can visit in Europe The Netflix hit follows a will-they-wont-they couple for 20 years across dreamy European destinations. 15/02/2024
Now playing Next Markets Novo Nordisk crossroads: Can the pharma giant address the supply woes? Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision. 10/02/2024
